Xeris Biopharma Holdings, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Xeris Biopharma Holdings, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2023.
  • Xeris Biopharma Holdings, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $694K, a 3.88% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $694K -$28K -3.88% Dec 31, 2023 10-K 2024-03-06
Q4 2022 $722K +$95K +15.2% Dec 31, 2022 10-K 2024-03-06
Q4 2021 $627K -$302K -32.5% Dec 31, 2021 10-K 2024-03-06
Q4 2020 $929K -$16K -1.69% Dec 31, 2020 10-K 2024-03-06
Q4 2019 $945K Dec 31, 2019 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.